hexamethonium has been researched along with Brain Hemorrhage, Cerebral in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Skarphedinsson, JO | 1 |
Delle, M | 1 |
Carlsson, S | 1 |
Bealer, SL | 1 |
Iitake, K | 1 |
Share, L | 1 |
Brooks, DP | 1 |
Crofton, JT | 1 |
Ouchi, Y | 1 |
2 other studies available for hexamethonium and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
The effects of hexamethonium on cerebral blood flow and cerebral function during relative cerebral ischaemia in rats.
Topics: Animals; Blood Pressure; Brain Ischemia; Brain Stem; Cerebral Hemorrhage; Cerebrovascular Circulatio | 1996 |
Role of brain acetylcholine in vasopressin release during osmotic stimulation and hemorrhage.
Topics: Acetylcholine; Animals; Atropine; Cerebral Hemorrhage; Cholinergic Fibers; Hexamethonium; Hexamethon | 1989 |